MET Valuation

MetLife Inc

Add to Watchlist

Advanced Chart

71.400

+0.290(+0.410%)

Overview
Forecast
Valuation

MET Relative Valuation

MET's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MET is overvalued; if below, it's undervalued.

Historical Valuation

MetLife Inc (MET) is now in the Undervalued zone, suggesting that its current forward PE ratio of 7.71 is considered Undervalued compared with the five-year average of 8.20. The fair price of MetLife Inc (MET) is between 76.54 to 94.72 according to relative valuation methord. Compared to the current price of 71.40 USD , MetLife Inc is Undervalued By 6.71%.

Relative Value

Fair Zone

76.54-94.72

Current Price：71.40

6.71%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.79

P/B

Median3y

1.71

Median5y

1.29

30.01

FCF Yield

Median3y

26.32

Median5y

26.75

Competitors Valuation Multiple

The average P/S ratio for MET's competitors is 1.56, providing a benchmark for relative valuation. MetLife Inc Corp (MET) exhibits a P/S ratio of 0.65, which is -58.50% above the industry average. Given its robust revenue growth of -1.71%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap